Dr. Roxanne Dryden-Edwards is an adult, child, and adolescent psychiatrist. She is a former Chair of the Committee on Developmental Disabilities for the American Psychiatric Association, Assistant Professor of Psychiatry at Johns Hopkins Hospital in Baltimore, Maryland, and Medical Director of the National Center for Children and Families in Bethesda, Maryland.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
The prognosis for ADHD individuals tends
to be influenced by the severity of symptoms, intelligence scores, whether or
not the ADHD sufferer has other mental-health conditions, as well as the
person's family issues, such as parental mental-health problems, family
problems, socioeconomic status, and if the person with ADHD receives treatment.
Stimulant treatment of ADHD improves the prognosis for adults, in that it
decreases the risk for developing other psychiatric problems and for failing in
Is it possible to prevent adult ADHD?
Studies indicate that breastfeeding up to 6 months of age may help protect
individuals from developing ADHD. As environmental
and social insults like maternal drug use, medical, and emotional issues are risk
factors for developing ADHD, prevention or treatment of those issues can help
prevent ADHD. Also, early treatment of children with ADHD can decrease the
condition's impact on the person's life as they move into adulthood.
Are support groups available for those with adult ADHD?
American Psychiatric Association. Diagnostic and Statistical Manual of Mental
Disorders, Fifth Edition. Arlington, Virginia: American Psychiatric Association, 2013.
Arnold, V.K., D. Feifel, C.Q. Earl, et al. "A 9-Week, randomized, double-blind,
placebo-controlled, parallel-group, dose-finding study to evaluate the efficacy
and safety of modafinil as treatment for adults with ADHD." Journal of Attention
Disorders May 2012.
Biederman, J., M.C. Monuteaux, T. Spencer, et al. "Do stimulants protect against
psychiatric disorders in youth with ADHD? A 10-year follow-up study." Pediatrics
124.1 July 2009: 71-78.
Bussing, R., D.M. Mason, L. Bell, P. Porter, and C. Garvan. "Adolescent outcomes of
childhood attention-deficit/hyperactivity disorder in a diverse community
sample." Journal of the American Academy of Child and Adolescent Psychiatry 49.6 June 2010: 595-605.
Clay, R.A. "Easing ADHD without meds." Monitor on Psychology 44.2 Feb.
Conners, C.K., D. Erhardt, J.N. Epstein, et al. "Self-ratings of
ADHD symptoms in adults I: Factor structure and normative data." Journal of
Attention Disorders 3.3 Oct. 1999: 141-151.
Curatolo, P., E. D'Agati, and R. Moavero. "The neurobiological basis of ADHD." Italian
Journal of Pediatrics 36 (2010): 79.
Hines, J.L., T.S. King, and W.J. Curry. "The adult ADHD self-report scale for screening
for adult attention deficit-hyperactivity disorder (ADHD)." Journal of the
American Board of Family Medicine 25.6 Nov.-Dec. 2012: 847-853.
Ingram, S., L. Hechtman, and G. Morgenstern. "Outcome issues in ADHD: Adolescent and adult
long-term outcome." Mental Retardation and Developmental Disabilities Research
Reviews 5.3 (1999): 243-250.
Lake, J. "Integrative management of ADHD: What the
evidence suggests." Psychiatric Times July 2010.
Millstein, R.B., T.E. Wilens, J. Biederman, and T.J. Spencer. "Presenting ADHD symptoms
and subtypes in clinically referred adults with ADHD." Journal of Attention
Disorders 2.3 Oct. 1997: 159-166.
Mimouni-Bloch, A., A. Kachevanskaya, F.B. Mimouni, et al. "Breastfeeding may
protect from developing attention-deficit hyperactivity disorder." Breastfeeding
Medicine May 2013.
Quintero, J., M. Loro, B. Jimenez, and N. Garcia Campos. "Evolutionary issues in
attention deficit hyperactivity disorder (ADHD); from risk factors to
comorbidity and social and academic impact." Vertex 22.96 Mar.-Apr. 2011:
Sagiv, S.K., J.N. Epstein, D.C. Bellinger, and S.A. Korrick. "Pre- and Postnatal Risk
Factors for ADHD in a Nonclinical Pediatric Population." Journal of Attention
Disorders 17.1 Jan. 2013: 47-57.
Taylor, F.B., and J. Russo. "Efficacy of modafinil
compared to dextroamphetamine for the treatment of attention deficit
hyperactivity disorder in adults." Journal of Child and Adolescent
Psychopharmacology 10.4 Winter 2000: 311-320.
Thapar, A., and M. Rutter. "Do prenatal
risk factors cause psychiatric disorder? Be wary of causal claims." The British
Journal of Psychiatry 195 (2009): 100-101.
Weiss, M., and C. Murray. "Assessment and management of attention-deficit
hyperactivity disorder in adults." Canadian Medical Association Journal 168.6 Mar. 2003.
Wilens, T.E., S.V. Faraone, J. Biederman, and S. Gunawardene. "Does stimulant therapy of
attention-deficit/hyperactivity disorder beget later substance abuse? A
meta-analytic review of the literature." Pediatrics 111.1 Jan. 2003:
Reviewed by William C. Shiel Jr., MD, FACP, FACR on 10/7/2013